Reviva Pharmaceuticals Holdings, Inc. (RVPH) earnings
RVPH earnings moved a median of +2.80% by the close. Quarterly and annual RVPH reports and results, each read against the price at its own news timestamp. Back to the RVPH overview →
20 measured RVPH earnings events.
Where these RVPH earnings landedvs 20 measured RVPH earnings reactions
| Middle 50% of RVPH earnings reactions | -6.25% to +8.21% |
|---|---|
| Median reaction (to close) | +2.80% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 RVPH earnings events with a measured close landed between -6.25% and +8.21%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +3.58% | +9.54% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -8.79% | +8.88% | |
| Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | -8.79% | +8.88% | |
| Form 10-K REVIVA PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +1.39% | -12.55% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.02% | +10.20% | |
| Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | -0.02% | +10.20% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.21% | |
| Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | +0.00% | -1.21% | |
| Form 10-K REVIVA PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -2.46% | -0.97% | |
| Form NT 10-K REVIVA PHARMACEUTICALS For: Dec 31 | SEC filing · Form NT | +0.16% | -33.96% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -5.00% | -6.25% | |
| Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | -5.00% | -6.25% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +4.47% | +4.15% | |
| Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | +4.47% | +4.15% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.89% | +7.99% | |
| Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | +0.89% | +7.99% | |
| Form 10-K REVIVA PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -3.79% | +1.46% | |
| Form NT 10-K REVIVA PHARMACEUTICALS For: Dec 31 | SEC filing · Form NT | -0.30% | +5.79% | |
| Form 10-Q REVIVA PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.89% | -9.09% | |
| Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights | Press release | -0.89% | -9.09% |
Keep exploring
More RVPH: analyst actions → · SEC filings → · RVPH overview →